The Bristol Myers Squibb Foundation

This signature program leverages lessons from our decade of work addressing lung cancer disparities in the US and focuses on building the capacity to better diagnose and treat lung cancer, while we remain committed to other high disease burden cancers prevalent in the countries where we are working.

This work is aligned with the BMS Pediatric Center of Excellence’s Mission “to be one of the world’s leading biopharma companies that transform pediatric patients’ lives through science”, with a commitment to being a leader in the wider pediatric community. This work includes pediatric cancers, sickle cell disease, and beta thalassemia​.

Our newest grant program in the US, focused on schizophrenia, supports the diversion of patients with serious mental illness from the criminal justice system into critical community-based mental health services.

The Winn Award Program addresses the priority of increasing inclusion in clinical trials. By training the next generation of clinical trialists in the science of community engagement, we believe we can include more patients in clinical trials that match the epidemiology of the disease studied. Research areas include cancer, cardiovascular disease, and neuropsychiatry.